IP Library Granted Patent US 8,367,041
Granted Patent B2
US 8,367,041 · App. 12/441,822 · Granted Feb 5, 2013

Radiographic contrast agent for postmortem, experimental and diagnostic angiography

Inventors: Silke Grabherr (Murten, CH); Erich Gygax (Bern, CH)
Assignee: Forim-X AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,367,041
App. No.
12/441,822
Granted
Feb 5, 2013
Kind
B2
Abstract

A contrast agent for angiography is disclosed, in particular, for examining animal or human bodies or components thereof such as members or organs thereof, comprising an essentially oil-based apolar contrast component for X-ray examinations, the contrast component having a contrast component viscosity in the range of 30-100 mPas. The contrast agent is characterised in that the contrast component is present in a mixture with at least one further apolar component, the viscosity of which is less than or at most equal to the contrast component viscosity. Methods for angiography examination are also disclosed, in which such a contrast agent or also a polar contrast agent are used at least periodically and applications of such contrast agents.

Claims (10)

1. A contrast agent for postmortem, experimental or diagnostic angiography and for examination of animal or human corpses or components thereof, comprising:

an essentially oil-based, non-polar contrast component for X-ray examinations, said contrast component having a contrast component viscosity in the range of 30-100 mPas,

wherein the contrast component is present in a mixture with at least one first further non-polar component of a viscosity, which is lower or at the most equal to the contrast component viscosity, and a second further non-polar component having a viscosity in the range of 25-80 mPas,

wherein the contrast agent is essentially free from water,

wherein the first further non-polar component is hexadecane or tetradecane, and

wherein the contrast component and the second further non-polar component are used in a ratio of 1:5 and the first further non-polar component is used in a ratio of 50:1 to the mixture of the contrast component and the second further non-polar component.

2. The contrast agent according to claim 1 , wherein the contrast component has a viscosity in the range of 30-80 mPas.

3. The contrast agent according to claim 2 , wherein the contrast component is an iodine-based or sulphur-based radiographic contrast agent.

4. The contrast agent according to claim 2 , wherein the contrast component is an iodized or brominated component or oil.

5. The contrast agent according to claim 1 , wherein the contrast component is selected from the group consisting of a propyliodone, a fatty-acid-ethyl ester of iodized poppy-seed oil, and an iodipine.

Assignments (2)
MERGER Recorded Oct 20, 2017
From: FORIM-X AG
To: FUMEDICA AG
Reel/Frame 043916/0599 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2009
From: GRABHERR, SILKE; GYGAX, ERICH
To: FORIM-X AG
Reel/Frame 022630/0490 →
Priority Claims (2)
CH 1485/06 · Sep 18, 2006 · national
CH 0212/07 · Feb 8, 2007 · national
Continuity (1)
Related Publication 20100021389A1 · Jan 28, 2010